Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 6 | 2024 | 218 | 0.850 |
Why?
|
| Genome-Wide Association Study | 9 | 2024 | 423 | 0.680 |
Why?
|
| Genetic Predisposition to Disease | 16 | 2024 | 734 | 0.660 |
Why?
|
| Lymphocytes | 1 | 2019 | 124 | 0.570 |
Why?
|
| Neutrophils | 1 | 2019 | 145 | 0.560 |
Why?
|
| DNA Mismatch Repair | 5 | 2024 | 28 | 0.550 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 163 | 0.510 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 224 | 0.490 |
Why?
|
| Colonic Neoplasms | 4 | 2024 | 223 | 0.410 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2024 | 863 | 0.380 |
Why?
|
| Colorectal Neoplasms | 6 | 2015 | 512 | 0.330 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 154 | 0.330 |
Why?
|
| Germ-Line Mutation | 3 | 2020 | 75 | 0.320 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 1723 | 0.290 |
Why?
|
| Glucuronosyltransferase | 2 | 2019 | 29 | 0.290 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 67 | 0.270 |
Why?
|
| Genotype | 7 | 2020 | 800 | 0.230 |
Why?
|
| Registries | 7 | 2020 | 437 | 0.230 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 3 | 2012 | 19 | 0.230 |
Why?
|
| Aged | 16 | 2024 | 8214 | 0.200 |
Why?
|
| Middle Aged | 18 | 2024 | 12222 | 0.200 |
Why?
|
| Humans | 32 | 2024 | 43102 | 0.190 |
Why?
|
| Female | 25 | 2024 | 24698 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 374 | 0.180 |
Why?
|
| Odds Ratio | 3 | 2019 | 587 | 0.160 |
Why?
|
| Case-Control Studies | 7 | 2024 | 1285 | 0.160 |
Why?
|
| Nicotine | 1 | 2023 | 302 | 0.150 |
Why?
|
| Male | 19 | 2024 | 23409 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 609 | 0.150 |
Why?
|
| Risk Factors | 10 | 2024 | 3994 | 0.140 |
Why?
|
| Receptors, Calcitriol | 1 | 2019 | 69 | 0.140 |
Why?
|
| Nitrosamines | 1 | 2018 | 11 | 0.140 |
Why?
|
| Glucuronides | 1 | 2018 | 25 | 0.140 |
Why?
|
| Estrogen Receptor beta | 2 | 2008 | 39 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 638 | 0.130 |
Why?
|
| Genetic Variation | 3 | 2008 | 430 | 0.130 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 561 | 0.120 |
Why?
|
| Mutation | 3 | 2012 | 1177 | 0.120 |
Why?
|
| Logistic Models | 3 | 2019 | 1009 | 0.120 |
Why?
|
| Adiposity | 1 | 2017 | 157 | 0.120 |
Why?
|
| DNA Repair | 2 | 2008 | 198 | 0.120 |
Why?
|
| CpG Islands | 1 | 2015 | 109 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 415 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 495 | 0.110 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 22 | 0.100 |
Why?
|
| Obesity | 2 | 2023 | 1151 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 82 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 83 | 0.100 |
Why?
|
| Prognosis | 4 | 2024 | 861 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2013 | 168 | 0.100 |
Why?
|
| Haplotypes | 3 | 2008 | 197 | 0.100 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 2853 | 0.100 |
Why?
|
| Smoking | 2 | 2010 | 1024 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2544 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 27 | 0.090 |
Why?
|
| Survivors | 1 | 2013 | 152 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 104 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2015 | 403 | 0.090 |
Why?
|
| Exercise | 1 | 2017 | 692 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2020 | 1759 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 5 | 0.080 |
Why?
|
| Receptors, Somatostatin | 1 | 2010 | 3 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2010 | 321 | 0.080 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 35 | 0.080 |
Why?
|
| Computational Biology | 1 | 2012 | 327 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 81 | 0.080 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2009 | 1 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2010 | 125 | 0.080 |
Why?
|
| Prostatic Neoplasms | 2 | 2010 | 1092 | 0.080 |
Why?
|
| DNA Glycosylases | 1 | 2008 | 17 | 0.070 |
Why?
|
| Databases, Genetic | 2 | 2020 | 103 | 0.070 |
Why?
|
| Asthma | 1 | 2011 | 416 | 0.070 |
Why?
|
| Adult | 10 | 2020 | 13872 | 0.060 |
Why?
|
| Microsatellite Instability | 3 | 2012 | 48 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 201 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 241 | 0.060 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2006 | 3 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 291 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 515 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2005 | 20 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 2021 | 86 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2006 | 144 | 0.060 |
Why?
|
| Leucovorin | 1 | 2024 | 5 | 0.050 |
Why?
|
| Organoplatinum Compounds | 1 | 2024 | 19 | 0.050 |
Why?
|
| Morbidity | 1 | 2004 | 97 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2024 | 53 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2024 | 47 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 12 | 0.050 |
Why?
|
| Cause of Death | 1 | 2004 | 186 | 0.050 |
Why?
|
| Family Health | 2 | 2015 | 55 | 0.050 |
Why?
|
| Butyric Acid | 1 | 2023 | 19 | 0.050 |
Why?
|
| Cotinine | 1 | 2023 | 44 | 0.050 |
Why?
|
| Life Style | 1 | 2004 | 334 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 228 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 220 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 968 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 182 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 455 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 241 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2010 | 863 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 88 | 0.040 |
Why?
|
| Genome, Human | 1 | 2021 | 144 | 0.040 |
Why?
|
| Family | 2 | 2013 | 195 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2020 | 91 | 0.040 |
Why?
|
| Young Adult | 3 | 2020 | 5080 | 0.040 |
Why?
|
| Pedigree | 2 | 2013 | 94 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 149 | 0.040 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2012 | 32 | 0.040 |
Why?
|
| Follistatin | 1 | 2019 | 28 | 0.040 |
Why?
|
| Microsatellite Repeats | 2 | 2012 | 61 | 0.040 |
Why?
|
| United States | 3 | 2019 | 5205 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 90 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 118 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2019 | 126 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 408 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 934 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2018 | 2 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2018 | 5 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2019 | 195 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 213 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 139 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 701 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2017 | 34 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1081 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 100 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 2157 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 333 | 0.030 |
Why?
|
| Vitamin D | 1 | 2019 | 196 | 0.030 |
Why?
|
| Heterozygote | 2 | 2008 | 110 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 90 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 200 | 0.030 |
Why?
|
| Risk | 2 | 2008 | 287 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 273 | 0.030 |
Why?
|
| Proteins | 1 | 2018 | 382 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 2676 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 6081 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 236 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2017 | 925 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2012 | 62 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 95 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2012 | 24 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 317 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2012 | 94 | 0.020 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 5 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 780 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 518 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 159 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 27 | 0.020 |
Why?
|
| DNA | 1 | 2013 | 592 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 186 | 0.020 |
Why?
|
| Age of Onset | 1 | 2010 | 114 | 0.020 |
Why?
|
| Fathers | 1 | 2010 | 38 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 458 | 0.020 |
Why?
|
| Australia | 1 | 2008 | 103 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1078 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1857 | 0.020 |
Why?
|
| Canada | 1 | 2008 | 163 | 0.020 |
Why?
|
| Mothers | 1 | 2010 | 215 | 0.020 |
Why?
|
| Exons | 1 | 2007 | 92 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1154 | 0.020 |
Why?
|
| Alleles | 1 | 2008 | 352 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 490 | 0.020 |
Why?
|
| Base Pair Mismatch | 1 | 2005 | 15 | 0.010 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2005 | 10 | 0.010 |
Why?
|
| SEER Program | 1 | 2005 | 164 | 0.010 |
Why?
|
| Pacific Islands | 1 | 2004 | 123 | 0.010 |
Why?
|
| Neoplasms | 2 | 2005 | 1377 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 257 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2004 | 246 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 1600 | 0.010 |
Why?
|
| Risk-Taking | 1 | 2004 | 457 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 541 | 0.010 |
Why?
|
| Prevalence | 1 | 2004 | 1612 | 0.010 |
Why?
|
| Hawaii | 1 | 2004 | 2011 | 0.010 |
Why?
|